These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 22018135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
    Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L.
    Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
    [Abstract] [Full Text] [Related]

  • 10. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
    Pitts SA, Feldman HA, Dorale A, Gordon CM.
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):23-6. PubMed ID: 22078997
    [Abstract] [Full Text] [Related]

  • 15. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N, Bahamondes L, Bahamondes MV, Bottura BF, Monteiro I.
    Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
    [Abstract] [Full Text] [Related]

  • 16. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.